Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Efficacy of topiramate

J Bruni1

  • 1Division of Neurology, Wellesley Central Hospital, University of Toronto, Canada.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|August 26, 1998
PubMed
Summary

Topiramate (Topamax) effectively reduces seizure frequency in patients with refractory epilepsy, including complex partial and generalized tonic-clonic seizures. This new antiepileptic drug shows broad-spectrum activity and favorable efficacy compared to other treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term open multicentre, add-on trial of vigabatrin in adult resistant partial epilepsy. The Canadian Vigabatrin Study Group.

Seizure·2000
Same author

Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group.

Seizure·2000
Same author

A STAT cardiac marker system for detecting acute heart attacks.

American clinical laboratory·1999
Same author

Gabapentin as adjunctive therapy for partial seizures.

Epilepsia·1999
Same author

Women's issues in the treatment of epilepsy.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·1998
Same author

Outcome evaluation of gabapentin as add-on therapy for partial seizures. "NEON" Study Investigators Group. Neurontin Evaluation of Outcomes in Neurological Practice.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·1998

Area of Science:

  • Neurology
  • Clinical Pharmacology

Background:

  • Epilepsy is a chronic neurological disorder characterized by recurrent seizures.
  • Refractory epilepsy poses significant treatment challenges, necessitating novel therapeutic options.
  • Topiramate is an antiepileptic drug with a known mechanism of action.

Purpose of the Study:

  • To evaluate the efficacy of topiramate in patients with refractory epilepsy.
  • To assess the broad-spectrum activity of topiramate across different epilepsy types.
  • To compare the efficacy of topiramate with other recently introduced antiepileptic drugs.

Main Methods:

  • Controlled clinical trials were conducted.
  • Open-label trials were utilized to assess broad-spectrum activity.
  • Patient populations included those with complex partial seizures, secondarily generalized tonic-clonic seizures, and primary generalized epilepsies.

Main Results:

  • Approximately 45% of 534 patients experienced a ≥50% reduction in seizure frequency.
  • Topiramate demonstrated efficacy in refractory patients with complex partial and secondarily generalized tonic-clonic seizures.
  • Limited open-label trials suggest broad-spectrum activity, potentially benefiting patients with primary generalized epilepsies.

Conclusions:

  • Topiramate is an effective treatment option for refractory epilepsy.
  • The drug exhibits favorable efficacy compared to other new antiepileptic drugs.
  • Topiramate demonstrates potential for broad-spectrum use in various epilepsy types.

Related Experiment Videos